Hibiclens for Georgia Pacific

Manufacturer
Georgia-Pacific Consumer Products LP
Effective date
2022-12-15
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:52:30

Label at a glance#

ProductHibiclens for Georgia Pacific
Active ingredientCHLORHEXIDINE GLUCONATE
Label structure13 sections

Indications and uses

antimicrobial skin cleanser helps reduce bacteria that potentially can cause disease surgical hand scrub healthcare personnel handwash

Dosage and administration

use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns. surgical hand scrub. Wet hands and forearms with water. Scrub for 3 minutes with about 5mL (8 pumps) of the product with a brush. Rinse thoroughly under running water. Repeat. Dry thoroughly. healthcare personnel handwash. Wet hands with water. Dispense about 5mL (8 pumps) of the product into...

Storage and handling

store between 20-25°C (68-77°F) avoid excessive heat above 40°C (104°F)

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Chlorhexidine gluconate solution 4% w/v

OTC - PURPOSE SECTION

Antiseptic

Uses

INDICATIONS & USAGE SECTION

  • antimicrobial skin cleanser helps reduce bacteria that potentially can cause disease
  • surgical hand scrub
  • healthcare personnel handwash

Warnings

WARNINGS SECTION

For external use only

Allergy alert:

WARNINGS SECTION

This product may cause a severe allergic reaction. Symptoms may include:

  • wheezing/difficulty breathing
  • shock
  • facial swelling
  • hives
  • rash

If an allergic reaction occurs, stop use and seek medical help right away.

Do not use

OTC - DO NOT USE SECTION

  • If you or the patient is allergic to chlorhexidine gluconate or any other ingredient in this product

When using this product

OTC - WHEN USING SECTION

  • keep out of eyes, ears, and mouth. May cause serious and permanent eye injury if permitted to enter and remain in the eye or may cause deafness when instilled in the middle ear through perforated eardrums.
  • if contact occurs in any of these areas, rinse with cold water right away
  • do not use routinely if you have wounds which involve more than the superficial layers of the skin

Stop use and ask a doctor if

OTC - ASK DOCTOR SECTION

irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns.
  • surgical hand scrub. Wet hands and forearms with water. Scrub for 3 minutes with about 5mL (8 pumps) of the product with a brush. Rinse thoroughly under running water. Repeat. Dry thoroughly.
  • healthcare personnel handwash. Wet hands with water. Dispense about 5mL (8 pumps) of the product into cupped hands and wash in a vigorous manner for 15 seconds. Rinse and dry thoroughly.

Other information

STORAGE AND HANDLING SECTION

  • store between 20-25°C (68-77°F)
  • avoid excessive heat above 40°C (104°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

fragrance, gluconalactone, isopropyl alcohol 4% w/v, lauramine oxide, poloxamer 237, purified water and red 40

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

54622-575-73_Drug Facts and PDP54622-575-73_Drug Facts and PDP

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
211365chlorhexidine gluconate 4 % Medicated Liquid SoapPSN2
834167HIBICLENS 4 % Medicated Liquid SoapPSN2
834167chlorhexidine gluconate 40 MG/ML Medicated Liquid Soap [Hibiclens]SBD2
211365chlorhexidine gluconate 40 MG/ML Medicated Liquid SoapSCD2
211365chlorhexidine gluconate 4 % Medicated Liquid SoapSY2
211365chlorhexidine gluconate 4 % Medicated Surgical ScrubSY2
834167Hibiclens 4 % Medicated Liquid SoapSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHLORHEXIDINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
bb6d6c68-649d-4e6d-a1f6-603d969c8f68Product name120160303

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
54622-575-732024-01-30C16284748780-11030e365-5080-111a-e063-dadaa90a10e2Hibiclens for Georgia Pacific

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54622-575-73Hibiclens for Georgia Pacific1200 mL in 1 BOTTLE, DISPENSINGSOLUTION12002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54622-575HIBICLENS FOR GEORGIA PACIFIC (CHLORHEXIDINE GLUCONATE) SOLUTION [GEORGIA-PACIFIC CONSUMER PRODUCTS LP]2Legacy NDC, 1 package rows20221217_d9a397a0-9484-34ef-e053-2995a90a642b.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54622-57554622-575-73

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N017768-001HIBICLENSCHLORHEXIDINE GLUCONATE4%SOLUTION / TOPICALRLD, RS, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N017768-001HIBICLENS4%SOLUTION / TOPICALRLD, RS, Approved before 1982f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
efe2af77-c6c9-27e3-e053-2a95a90ad1ecd9a397a0-9484-34ef-e053-2995a90a642b2022-12-15WarningsExact identifier
spl id: efe2af77-c6c9-27e3-e053-2a95a90ad1ec
spl set id: d9a397a0-9484-34ef-e053-2995a90a642b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.